Massive COVID-19 biobank aims to unlock secrets of severe disease
NCT ID NCT04318366
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is collecting medical information and biological samples from up to 6,000 people with COVID-19. Researchers want to find out which factors predict severe illness, death, or response to treatment. The goal is to better understand the disease and help guide future care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONAVIRUS INFECTIONS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AIDS Immunopathogenesis Unit - IRCCS San Raffaele Scientific Institute
RECRUITINGMilan, Lombardy, 20132, Italy
-
Autoimmunity and Vascular Inflammation Unit, Division of Regenerative Medicine, Stem Cells and Gene Therapy - IRCCS San Raffaele Scientific Institute
RECRUITINGMilan, Lombardy, 2012, Italy
-
Department of Infection Diseases - IRCCS San Raffaele Scientific Institute -
RECRUITINGMilan, Lombardy, 20132, Italy
-
Department of Internal Medicine - IRCCS San Raffaele Scientific Institute
RECRUITINGMilan, Lombardy, 20132, Italy
-
Diabetes Research Institute -IRCCS San Raffaele Scientific Istitute
RECRUITINGMilan, Lombardy, 20132, Italy
-
Division of Immunology, Transplantation and Infectious Diseases - IRCCS San Raffaele Scientific Institute
RECRUITINGMilan, Lombardy, 20132, Italy
-
Division of Research of Regenerative Medicine, Cell and Gene Therapy - IRCCS San Raffaele Scientific Istitute
RECRUITINGMilan, Lombardy, 20132, Italy
-
Laboratory of Microbiology and Virology - IRCCS San Raffaele Scientific Institute
RECRUITINGMilan, Lombardy, 20132, Italy
-
Nephrology Unit - IRCCS San Raffaele Scientific Institute
RECRUITINGMilan, Lombardy, 20132, Italy
-
Strategic Program in Nephrology and Dialysis - IRCCS San Raffaele Scientific Institute
RECRUITINGMilan, Lombardy, 20132, Italy
-
Unit of Immunology, Rheumatology, Allergy and Rare Diseases - IRCCS San Raffaele Scientific Institute
RECRUITINGMilan, Lombardy, 2132, Italy
-
Università Vita-Salute San Raffaele
RECRUITINGMilan, Mi, 20132, Italy
-
Viral pathogens and biosafety Unit - IRCCS San Raffaele Scietific Institute
RECRUITINGMilan, Lombardy, 20132, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Five years on: how does long COVID evolve?
- Can a targeted pill tame severe COVID-19?
- Can an organic compound tame COVID-19 in High-Risk patients?
- Could exercise retrain the heart in long COVID?
- Can a new drug shield lungs from COVID-19's worst damage?
- Can paxlovid hold the line against severe COVID-19 outside the lab?